ABI2‐mediated MEOX2/KLF4‐NANOG axis promotes liver cancer stem cell and drives tumour recurrence

Tumour recurrence and drug resistance in hepatocellular carcinoma remain challenging. Cancer stem cells (CSCs) are responsible for tumour initiation because of their stemness characteristics. CSCs accounting for drug resistance and tumour relapse are promising therapeutic targets. We report that Abe...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jiandi, Li, Huizi, Zhang, Bin, Xiong, Zhiyuan, Jin, Zhe, Chen, Jiaxi, Zheng, Yang, Zhu, Xiangnan, Zhang, Shuixing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Experimental Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825985/
https://www.ncbi.nlm.nih.gov/pubmed/36017822
http://dx.doi.org/10.1111/liv.15412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825985/
https://www.ncbi.nlm.nih.gov/pubmed/36017822
http://dx.doi.org/10.1111/liv.15412

Ejemplares similares